trending Market Intelligence /marketintelligence/en/news-insights/trending/ecscjigc7hcqrdkha7ofva2 content esgSubNav
In This List

Cellectis director to retire

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Cellectis director to retire

Jean-Marie Messier will not stand for re-election to Cellectis SA's board.

The director will retire ahead of the French biopharmaceutical company's June 26 shareholders' meeting.

Cellectis said Messier's decision was not a result of any dispute or disagreement with the company or its board.